Relapsed/refractory early T-cell precursor acute lymphoblastic leukemia was salvaged by venetoclax plus HAG regimen

Ann Hematol. 2020 Feb;99(2):395-397. doi: 10.1007/s00277-019-03902-9. Epub 2019 Dec 26.

Xiang Zhang^{1

2

3}, Jianhu Li^{1

4}, Jie Jin^{1

2

3}, Wenjuan Yu^{5

6

7}

¹ Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, 310003, Zhejiang, China.
² Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.
³ Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Zhejiang, Hangzhou, Zhejiang, China.
⁴ Bone marrow morphology laboratory, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China.
⁵ Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, 310003, Zhejiang, China. [email protected].
⁶ Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China. [email protected].
⁷ Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Zhejiang, Hangzhou, Zhejiang, China. [email protected].

No abstract available

Publication types